GELLER, DANIEL A. MBBS, FRACP1; BIEDERMAN, JOSEPH M.D.1; FARAONE, STEPHEN Ph.D.2; AGRANAT, ANAT M.D., M.Sc.3; CRADOCK, KATHLEEN B.A.1; HAGERMOSER, LISA B.A.1; KIM, GRACE M.A.R.1; FRAZIER, JEAN M.D.1; COFFEY, BARBARA J. M.D.1
1 Joint Program in Pediatric Psychopharmacology, Massachusetts General Hospital and McLean Hospital, Belmont, Massachusetts 02478. Send reprint requests to Dr. Daniel Geller, Pediatric OCD Clinic, McLean Hospital, 115 Mill Street, Belmont, Massachusetts 02478.
2 Harvard Medical School, Cambridge, Massachusetts.
3 Department of Child and Adolescent Psychiatry, Hadassah Mount Scopus Hospital, Hebrew University, Hadassah Medical School, Jerusalem, Israel.
This work has been funded in part by an Eli Lilly Pilot Research Award from the American Academy of Child and Adolescent Psychiatry, a Tourette Syndrome Association Foundation award, an Obsessive Compulsive Foundation award, as well as NIMH K08 MH01481.